What is the treatment for bronchitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Acute Bronchitis

Antibiotics should NOT be routinely prescribed for uncomplicated acute bronchitis, as they provide minimal benefit (reducing cough by only half a day) while exposing patients to adverse effects and contributing to antibiotic resistance. 1, 2, 3

Initial Assessment: Rule Out Pneumonia First

Before diagnosing uncomplicated acute bronchitis, you must exclude pneumonia by checking for:

  • Tachycardia (heart rate >100 beats/min) 3
  • Tachypnea (respiratory rate >24 breaths/min) 3
  • Fever (oral temperature >38°C) 3
  • Abnormal chest examination findings (rales, egophony, tactile fremitus, or asymmetrical lung sounds) 1, 3

Chest radiography is usually NOT indicated in healthy, nonelderly adults without vital sign abnormalities or asymmetrical lung sounds. 1, 4

First-Line Symptomatic Treatment

Bronchodilators (Preferred)

Albuterol (short-acting β-agonist) is the first-line symptomatic treatment for acute bronchitis, reducing both duration and severity of cough. 2

  • Approximately 50% fewer patients report presence of cough after 7 days of albuterol treatment 2
  • FDA-approved for relief of bronchospasm in patients ≥2 years with reversible obstructive airway disease 5
  • Administered via nebulizer: 2.5 mg/3 mL unit-dose vial, no dilution required, treatment takes 5-15 minutes 5
  • Most beneficial in patients with wheezing or evidence of bronchial hyperresponsiveness 2, 3

Alternative Symptomatic Options

  • Ipratropium bromide may improve cough in some patients 2, 4
  • Dextromethorphan or codeine provide modest effects on cough severity and duration, particularly for dry, bothersome cough that disturbs sleep 2, 3
  • Low-cost interventions such as elimination of environmental cough triggers and vaporized air treatments are reasonable 2, 3

When Antibiotics Are NOT Indicated

Do NOT prescribe antibiotics based on:

  • Duration of cough alone (cough typically lasts 10-14 days normally) 1, 2, 3
  • Presence of purulent or colored sputum (occurs in 89-95% of viral cases) 3, 6
  • Patient expectation for antibiotics 1, 3

Respiratory viruses cause 89-95% of acute bronchitis cases; fewer than 10% have bacterial infections. 3, 6

Exception: When Antibiotics ARE Indicated

Pertussis (Whooping Cough)

If pertussis is confirmed or suspected, prescribe a macrolide antibiotic (erythromycin or azithromycin). 3

  • Isolate patients for 5 days from start of treatment 3
  • Early treatment within first few weeks diminishes coughing paroxysms and prevents disease spread 3

Bacterial Superinfection

Consider antibiotics ONLY if fever >38°C persists beyond 3 days, strongly suggesting bacterial superinfection rather than viral bronchitis. 3

Patient Education (Critical for Satisfaction)

Patient satisfaction depends MORE on physician-patient communication than on receiving antibiotics. 1, 2, 3

Inform patients that:

  • Cough typically lasts 10-14 days after the office visit, even with treatment 2, 3
  • Most symptoms resolve within 3 weeks 3
  • Antibiotics will not significantly shorten the illness and carry risks of side effects 3

Consider referring to the condition as a "chest cold" rather than "bronchitis" to reduce patient expectations for antibiotics. 3

Special Populations Requiring Different Management

These guidelines apply to otherwise healthy adults. Different approaches are needed for:

  • Elderly patients (>75 years) 3
  • Immunocompromised patients 3
  • Patients with COPD, heart failure, or diabetes 3, 4
  • Patients with chronic bronchitis experiencing acute exacerbations 4, 7

For acute exacerbations of chronic bronchitis with risk factors (age ≥65, FEV1 <50%, ≥4 exacerbations in 12 months, comorbidities), antibiotics ARE indicated using the Anthonisen criteria (increased dyspnea, sputum volume, or sputum purulence). 3, 7

Common Pitfalls to Avoid

  • Prescribing antibiotics for uncomplicated acute bronchitis despite lack of evidence 2
  • Assuming bacterial infection based on sputum color or purulence alone (present in 89-95% of viral cases) 3
  • Failing to distinguish between acute bronchitis and pneumonia 4
  • Not providing realistic expectations about natural course of illness (10-14 day cough duration) 2
  • Overlooking bronchodilator therapy which has demonstrated benefit 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Bronchitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Acute Bronchitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Bronchitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evidence-based acute bronchitis therapy.

Journal of pharmacy practice, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.